首页 > 市场调查报告书 > 製药

疫苗

市场调查报告书

商品编码

1514974

基于 RNA 的治疗和疫苗市场，按产品类型、应用、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

RNA-based Therapeutics and Vaccines Market, By Product Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年06月04日 | 出版商:

AnalystView Market Insights | 英文 262 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

报告要点

2023 年，基于 RNA 的治疗和疫苗市场规模为 200 万美元，2024 年至 2032 年复合年增长率为 65.10%。

基于 RNA 的治疗与疫苗市场-市场动态

RNA 递送技术和个人化药物的进步预计将推动市场需求

基于 RNA 的疗法，例如 mRNA 疗法，有望实现个人化医疗。它们可以针对个别患者特有的特定基因突变或疾病机制进行客製化。这种客製化的潜力与精准医学的发展趋势相一致，即治疗越来越多地根据个体遗传特征和疾病特征进行客製化。因此，对个人化治疗和药物的需求增加预计将推动市场成长。此外，脂质奈米颗粒 (LNP) 和其他递送系统的进步显着提高了 RNA 疗法和疫苗的稳定性和效率。这些进步减少了商业化的障碍，并增强了基于 RNA 治疗各种疾病的可行性。

COVID-19 大流行凸显了快速开发疫苗的迫切需求。基于 RNA 的疫苗，例如 Pfizer-BioNTech 和 Moderna 开发的疫苗，在开发和部署方面表现出了前所未有的速度。这一经验加速了人们对 RNA 技术的兴趣和投资，以应对未来的大流行。 FDA 和 EMA 等监管机构已表示愿意加快基于 RNA 的疗法和疫苗的审查流程，特别是在突发公共卫生事件期间。这种监管支持缩短了上市时间，并鼓励对 RNA 技术的进一步投资。

基于 RNA 的治疗和疫苗市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 65.10% 左右的复合年增长率成长

根据产品类型细分，由于对 RNA 治疗药物的高需求，基于 RNA 的治疗药物预计将在 2023 年显示最大的市场份额。

根据应用细分，由于对治疗心血管疾病的 RNA 疫苗的需求不断增长，心血管疾病领域是 2023 年的领先应用。

根据最终用户细分，由于对慢性、遗传和心血管疾病治疗的高需求，医院细分市场将在 2023 年成为领先的最终用户。

从地区来看，由于传染病和遗传疾病的高发生率，北美将成为 2023 年的主要收入来源。

基于 RNA 的治疗和疫苗市场細項分析：

全球基于 RNA 的治疗和疫苗市场根据产品类型、应用、最终用户和地区进行细分。

根据产品类型，市场分为两类：基于 RNA 的治疗药物和基于 RNA 的疫苗。基于 RNA 的疫苗领域主导市场。对精准药物疫苗和疗法的高需求正在推动市场成长。

市场依应用分为七类：肿瘤学、免疫学、眼科、传染病、心血管疾病、遗传疾病等。心血管疾病领域占市场主导地位。遗传和免疫学相关疾病的增加以及遗传学的新研究正在推动细分市场的需求。

根据最终用户，市场分为三类：医院和诊所、研究实验室等。医院和诊所领域在市场中占据主导地位，预计在预测期内将保持其高度主导地位。随着疫苗研究和疗法的增加，研究实验室预计将以最快的速度扩张。

基于 RNA 的治疗和疫苗市场 - 地理洞察

在全球范围内，基于 RNA 的治疗和疫苗市场广泛分布于北美、拉丁美洲、欧洲、亚太地区、中东和非洲地区。北美主导全球市场。许多基于 RNA 的开创性疗法和疫苗都源自该地区的公司，并得到了强大研究机构和创投资金的支持。美国 FDA 在促进基于 RNA 的疗法的开发和批准方面的积极立场鼓励了美国的投资并加速了商业化。

基于 RNA 的治疗与疫苗市场-竞争格局：

基于 RNA 的治疗药物和疫苗市场的特点是几家主要公司之间竞争激烈。市场参与者正在积极推动以 RNA 为基础的疗法，涵盖多种疾病，包括癌症、遗传性疾病、传染病和代谢疾病。正在进行的临床试验和临床前研究旨在将 RNA 技术的治疗应用扩展到 COVID-19 大流行之外。学术界、生物技术公司和製药公司之间的合作正在推动基于 RNA 的疗法的创新。这些合作伙伴关係利用 RNA 生物学、药物传递和临床开发的不同专业知识，加速研究成果向商业产品的转化。

市场片段
- 基于 RNA 的治疗和疫苗市场片段（按产品类型）
- 基于 RNA 的治疗和疫苗市场片段（按应用）
- 最终用户的基于 RNA 的治疗和疫苗市场片段
- 基于 RNA 的治疗和疫苗市场片段（按国家/地区）
- 基于 RNA 的治疗和疫苗市场片段（按地区）
竞争洞察

第 3 章：基于 RNA 的治疗药物和疫苗主要市场趋势

基于 RNA 的治疗和疫苗市场驱动因素
- 市场驱动因素的影响分析
基于 RNA 的治疗和疫苗市场限制
- 市场限制影响分析
基于 RNA 的治疗和疫苗市场机会
基于 RNA 的治疗和疫苗市场未来趋势

第 4 章：基于 RNA 的治疗药物和疫苗产业研究

PEST分析
波特五力分析
成长前景图
规范架构分析

第 5 章：基于 RNA 的治疗和疫苗市场：COVID-19 影响分析

COVID-19 之前的影响分析
COVID-19 后影响分析
- 表现最佳的市场区隔
- 边际增长部分
- 最鬆散的部分
- 边际损失部分

第 6 章：基于 RNA 的治疗与疫苗市场格局

2024 年基于 RNA 的治疗药物和疫苗市场份额分析
按主要製造商分類的故障数据
- 既定玩家分析
- 新兴玩家分析

第 7 章：基于 RNA 的治疗和疫苗市场 - 按产品类型

概述
- 按产品类型分類的细分市场占有率分析
- 基于RNA的治疗
- 基于RNA的疫苗

第 8 章：基于 RNA 的治疗和疫苗市场 - 按应用

概述
- 按应用分類的细分市场占有率分析
- 肿瘤学
- 免疫学
- 眼科
- 传染病
- 心血管疾病
- 遗传疾病
- 其他的

第 9 章：基于 RNA 的治疗和疫苗市场 - 按最终用户

概述
- 按最终用户分類的细分市场占有率分析
- 医院及诊所
- 研究实验室
- 其他的

第 10 章：基于 RNA 的治疗和疫苗市场 - 按地理位置

介绍
- 按地理位置分類的细分市场占有率分析
北美洲
- 概述
- 北美基于 RNA 的治疗药物和疫苗主要製造商
- 北美市场规模和预测（按国家）
- 北美市场规模和预测（按产品类型）
- 北美市场规模和预测（按应用）
- 北美市场规模和预测（按最终用户）
- 我们
- 加拿大
欧洲
- 概述
- 欧洲基于 RNA 的治疗药物和疫苗主要製造商
- 欧洲市场规模和预测（按国家）
- 欧洲市场规模和预测（按产品类型）
- 欧洲市场规模和预测（按应用）
- 欧洲市场规模和预测（按最终用户）
- 德国
- 义大利
- 英国
- 法国
- 俄罗斯
- 荷兰
- 瑞典
- 波兰
- 欧洲其他地区
亚太地区 (APAC)
- 概述
- 亚太地区基于 RNA 的治疗药物和疫苗主要製造商
- 亚太地区市场规模与预测（按国家）
- 亚太地区市场规模与预测（依产品类型）
- 亚太地区市场规模与预测（按应用）
- 亚太地区市场规模和预测（按最终用户）
- 印度
- 中国
- 日本
- 韩国
- 澳洲
- 泰国
- 印尼
- 菲律宾
- 亚太地区其他地区
拉丁美洲
- 概述
- 拉丁美洲基于 RNA 的治疗药物和疫苗主要製造商
- 拉丁美洲市场规模与预测（按国家）
- 拉丁美洲市场规模与预测（按产品类型）
- 拉丁美洲市场规模与预测（按应用）
- 拉丁美洲市场规模和预测（按最终用户）
- 巴西
- 墨西哥
- 阿根廷
- 哥伦比亚
- 拉丁美洲其他地区
中东和非洲
- 概述
- 中东和非洲基于 RNA 的治疗药物和疫苗主要製造商
- 中东和非洲市场规模及预测（按国家）
- 中东和非洲市场规模及预测（按产品类型）
- 中东和非洲市场规模及预测（按应用）
- 中东和非洲市场规模和预测（按最终用户）
- 沙乌地阿拉伯
- 阿拉伯聯合大公国
- 以色列
- 土耳其
- 阿尔及利亚
- 埃及
- MEA 的其余部分

第 11 章：主要供应商分析 - 基于 RNA 的治疗和疫苗产业

竞争仪表板
公司简介
- Moderna, Inc.
- Pfizer-BioNTech
- CureVac
- Alnylam Pharmaceuticals
- Arrowhead Pharmaceuticals
- Translate Bio
- BioNTech SE
- Dicerna Pharmaceuticals
- Regulus Therapeutics
- Ionis Pharmaceuticals
- Sirnaomics
- Marina Biotech
- Sarepta Therapeutics
- Arcturus Therapeutics
- AstraZeneca
- Others

第 12 章：360 度分析师视角

第 13 章：附录

研究方法论
参考
缩写
免责声明
联络我们

简介目录图表

Product Code: ANV3080

REPORT HIGHLIGHT

The RNA-based Therapeutics and Vaccines Market size was valued at USD 2.0 Million in 2023, expanding at a CAGR of 65.10% from 2024 to 2032.

RNA-based therapeutics and vaccines represent a modern approach to medical treatments and disease prevention that utilizes RNA molecules as the primary agents for therapy or immunization. RNA vaccines can be developed and manufactured more rapidly than traditional vaccines, as they do not require the production of the pathogen itself.

RNA-based Therapeutics and Vaccines Market- Market Dynamics

Advancement in RNA delivery technologies and personalized medicines are expected to propel market demand

RNA-based therapeutics, such as mRNA therapy, hold promise for personalized medicine. They can be tailored to target specific genetic mutations or disease mechanisms unique to individual patients. This potential for customization aligns with the growing trend toward precision medicine, where treatments are increasingly tailored to individual genetic profiles and disease characteristics. Thus, increased demand for personalized therapies & medicine is expected to fuel the market growth. Additionally, advances in lipid nanoparticles (LNPs) and other delivery systems have significantly improved the stability and efficiency of RNA therapeutics and vaccines. These advancements reduce barriers to commercialization and enhance the feasibility of RNA-based treatments for various diseases.

The COVID-19 pandemic has underscored the urgent need for rapid vaccine development. RNA-based vaccines, such as those developed by Pfizer-BioNTech and Moderna, demonstrated unprecedented speed in development and deployment. This experience has accelerated interest and investment in RNA technology for future pandemic preparedness. Regulatory agencies, such as the FDA and EMA, have demonstrated willingness to expedite review processes for RNA-based therapies and vaccines, particularly during public health emergencies. This regulatory support reduces time to market and encourages further investment in RNA technology.

RNA-based Therapeutics and Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 65.10% over the forecast period (2024-2032)

Based on Product Type segmentation, the RNA-based Therapeutics segment was predicted to show maximum market share in the year 2023, owing to the high need for RNA therapeutics.

Based on Application segmentation, cardiovascular diseases segment was the leading Application in 2023, owing to rising demand for RNA vaccines in treatment of cardiovascular diseases.

Based on End User segmentation, hospitals segment was the leading End User in 2023, owing to high demand for treatment of chronic, genetic, and cardiovascular disorders.

On the basis of region, North America was the leading revenue generator in 2023, owing to high prevalence of infectious & genetic diseases.

RNA-based Therapeutics and Vaccines Market- Segmentation Analysis:

The Global RNA-based Therapeutics and Vaccines Market is segmented on the basis of Product Type, Application, End User, and Region.

The market is divided into two categories based on Product Type: RNA-based Therapeutics and RNA-based Vaccines. The RNA-based Vaccines segment dominates the market. High demand for precision medicinal vaccines & therapies are boosting market growth.

The market is divided into seven categories based on the Application: oncology, immunology, ophthalmology, infectious disease, cardiovascular disease, genetic disease, and others. The cardiovascular disease segment dominates the market. Rising genetic and immunology related diseases and new research in genetics is promoting segment demand.

The market is divided into three categories based on End User: hospitals & clinics, research laboratories, and others. The hospitals & clinics segment dominates the market and is expected to maintain its high dominance during the forecast period. Research laboratories is expected to expand at fastest rate with rise in vaccine research & therapies.

RNA-based Therapeutics and Vaccines Market- Geographical Insights

Worldwide, the RNA-based Therapeutics and Vaccines market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the global market. Many pioneering RNA-based therapeutics and vaccines originate from companies based in this region, supported by robust research institutions and venture capital funding. The US FDA's proactive stance on facilitating the development and approval of RNA-based therapies has encouraged investment and accelerated commercialization in the United States.

RNA-based Therapeutics and Vaccines Market- Competitive Landscape:

The market for RNA-based therapeutics and vaccines is characterized by intense competition among several key companies. Market players are actively advancing RNA-based therapies across a wide range of diseases, including cancer, genetic disorders, infectious diseases, and metabolic conditions. Ongoing clinical trials and preclinical research aim to expand the therapeutic applications of RNA technologies beyond the COVID-19 pandemic. Collaborations between academia, biotech firms, and pharmaceutical companies are driving innovation in RNA-based therapies. These partnerships leverage diverse expertise in RNA biology, drug delivery, and clinical development to accelerate the translation of research into commercial products.

Recent Developments:

In August 2023, CureVac collaborated with GSK for the development of bivalent mRNA COVID-19 vaccines.

In March 2022, Moderna has started second phase HIV vaccine trials.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET KEY PLAYERS

Moderna, Inc.
Pfizer-BioNTech
CureVac
Alnylam Pharmaceuticals
Arrowhead Pharmaceuticals
Translate Bio
BioNTech SE
Dicerna Pharmaceuticals
Regulus Therapeutics
Ionis Pharmaceuticals
Sirnaomics
Marina Biotech
Sarepta Therapeutics
Arcturus Therapeutics
AstraZeneca
Others

GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

RNA-based Therapeutics
RNA-based Vaccines

GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

Oncology
Immunology
Ophthalmology
Infectious disease
Cardiovascular disease
Genetic disease
Others

GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

Hospital & Clinics
Research Laboratories
Others

GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. RNA-based Therapeutics and Vaccines Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. RNA-based Therapeutics and Vaccines Market Snippet by Product Type
- 2.1.2. RNA-based Therapeutics and Vaccines Market Snippet by Application
- 2.1.3. RNA-based Therapeutics and Vaccines Market Snippet by End User
- 2.1.4. RNA-based Therapeutics and Vaccines Market Snippet by Country
- 2.1.5. RNA-based Therapeutics and Vaccines Market Snippet by Region
2.2. Competitive Insights

3. RNA-based Therapeutics and Vaccines Key Market Trends

3.1. RNA-based Therapeutics and Vaccines Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. RNA-based Therapeutics and Vaccines Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. RNA-based Therapeutics and Vaccines Market Opportunities
3.4. RNA-based Therapeutics and Vaccines Market Future Trends

4. RNA-based Therapeutics and Vaccines Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. RNA-based Therapeutics and Vaccines Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. RNA-based Therapeutics and Vaccines Market Landscape

6.1. RNA-based Therapeutics and Vaccines Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. RNA-based Therapeutics and Vaccines Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 7.1.2. RNA-based Therapeutics
- 7.1.3. RNA-based Vaccines

8. RNA-based Therapeutics and Vaccines Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 8.1.2. Oncology
- 8.1.3. Immunology
- 8.1.4. Ophthalmology
- 8.1.5. Infectious disease
- 8.1.6. Cardiovascular disease
- 8.1.7. Genetic disease
- 8.1.8. Others

9. RNA-based Therapeutics and Vaccines Market - By End User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
- 9.1.2. Hospital & Clinics
- 9.1.3. Research Laboratories
- 9.1.4. Others

10. RNA-based Therapeutics and Vaccines Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. RNA-based Therapeutics and Vaccines Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. RNA-based Therapeutics and Vaccines Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. RNA-based Therapeutics and Vaccines Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. RNA-based Therapeutics and Vaccines Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. RNA-based Therapeutics and Vaccines Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- RNA-based Therapeutics and Vaccines Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Moderna, Inc.
- 11.2.2. Pfizer-BioNTech
- 11.2.3. CureVac
- 11.2.4. Alnylam Pharmaceuticals
- 11.2.5. Arrowhead Pharmaceuticals
- 11.2.6. Translate Bio
- 11.2.7. BioNTech SE
- 11.2.8. Dicerna Pharmaceuticals
- 11.2.9. Regulus Therapeutics
- 11.2.10. Ionis Pharmaceuticals
- 11.2.11. Sirnaomics
- 11.2.12. Marina Biotech
- 11.2.13. Sarepta Therapeutics
- 11.2.14. Arcturus Therapeutics
- 11.2.15. AstraZeneca
- 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

简介目录图表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE RNA-based Therapeutics and Vaccines Market: Product Type Snapshot (2024)
TABLE Segment Dashboard; Definition and Scope, by Product Type
TABLE Global RNA-based Therapeutics and Vaccines Market, by Product Type 2019-2032 (USD Million)
TABLE RNA-based Therapeutics and Vaccines Market: Application Snapshot (2024)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global RNA-based Therapeutics and Vaccines Market, by Application 2019-2032 (USD Million)
TABLE RNA-based Therapeutics and Vaccines Market: End User Snapshot (2024)
TABLE Segment Dashboard; Definition and Scope, by End User
TABLE Global RNA-based Therapeutics and Vaccines Market, by End User 2019-2032 (USD Million)
TABLE RNA-based Therapeutics and Vaccines Market: Regional snapshot (2024)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global RNA-based Therapeutics and Vaccines Market, by Region 2019-2032 (USD Million)
TABLE North America RNA-based Therapeutics and Vaccines Market, by Country, 2019-2032 (USD Million)
TABLE North America RNA-based Therapeutics and Vaccines Market, by Product Type, 2019-2032 (USD Million)
TABLE North America RNA-based Therapeutics and Vaccines Market, by Application, 2019-2032 (USD Million)
TABLE North America RNA-based Therapeutics and Vaccines Market, by End User, 2019-2032 (USD Million)
TABLE Europe RNA-based Therapeutics and Vaccines Market, by Country, 2019-2032 (USD Million)
TABLE Europe RNA-based Therapeutics and Vaccines Market, by Product Type, 2019-2032 (USD Million)
TABLE Europe RNA-based Therapeutics and Vaccines Market, by Application, 2019-2032 (USD Million)
TABLE Europe RNA-based Therapeutics and Vaccines Market, by End User, 2019-2032 (USD Million)
TABLE Asia Pacific RNA-based Therapeutics and Vaccines Market, by Country, 2019-2032 (USD Million)
TABLE Asia Pacific RNA-based Therapeutics and Vaccines Market, by Product Type, 2019-2032 (USD Million)
TABLE Asia Pacific RNA-based Therapeutics and Vaccines Market, by Application, 2019-2032 (USD Million)
TABLE Asia Pacific RNA-based Therapeutics and Vaccines Market, by End User, 2019-2032 (USD Million)
TABLE Latin America RNA-based Therapeutics and Vaccines Market, by Country, 2019-2032 (USD Million)
TABLE Latin America RNA-based Therapeutics and Vaccines Market, by Product Type, 2019-2032 (USD Million)
TABLE Latin America RNA-based Therapeutics and Vaccines Market, by Application, 2019-2032 (USD Million)
TABLE Latin America RNA-based Therapeutics and Vaccines Market, by End User, 2019-2032 (USD Million)
TABLE Middle East and Africa RNA-based Therapeutics and Vaccines Market, by Country, 2019-2032 (USD Million)
TABLE Middle East and Africa RNA-based Therapeutics and Vaccines Market, by Product Type, 2019-2032 (USD Million)
TABLE Middle East and Africa RNA-based Therapeutics and Vaccines Market, by Application, 2019-2032 (USD Million)
TABLE Middle East and Africa RNA-based Therapeutics and Vaccines Market, by End User, 2019-2032 (USD Million)

List of Figures

FIGURE RNA-based Therapeutics and Vaccines Market Segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter's Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2024
FIGURE Product Type segment market share analysis, 2024 & 2032
FIGURE Product Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Application segment market share analysis, 2024 & 2032
FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE End User segment market share analysis, 2024 & 2032
FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Regional segment market share analysis, 2024 & 2032
FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE North America RNA-based Therapeutics and Vaccines Market share and leading players, 2024
FIGURE Europe RNA-based Therapeutics and Vaccines Market share and leading players, 2024
FIGURE Asia Pacific RNA-based Therapeutics and Vaccines Market share and leading players, 2024
FIGURE Latin America RNA-based Therapeutics and Vaccines Market share and leading players, 2024
FIGURE Middle East and Africa RNA-based Therapeutics and Vaccines Market share and leading players, 2024
FIGURE North America market share analysis by country, 2024
FIGURE U.S. RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Canada RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Europe RNA-based Therapeutics and Vaccines Market share analysis by country, 2024
FIGURE Germany RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Spain RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Italy RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE France RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE UK RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Russia RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Netherlands RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Sweden RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Poland RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of the Europe RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Asia Pacific RNA-based Therapeutics and Vaccines Market share analysis by country, 2024
FIGURE India RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE China RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Japan RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE South Korea RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Australia RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Thailand RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Indonesia RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Philipines RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of APAC RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Latin America RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Latin America RNA-based Therapeutics and Vaccines Market share analysis by country, 2024
FIGURE Brazil RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Mexico RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Argentina RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Colombia RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of LATAM RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Middle East and Africa RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Middle East and Africa RNA-based Therapeutics and Vaccines Market share analysis by country, 2024
FIGURE Saudi Arabia RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE United Arab Emirates RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Israel RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Turkey RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Algeria RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Egypt RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
FIGURE Rest of MEA RNA-based Therapeutics and Vaccines Market size, forecast and trend analysis, 2019 to 2032 (USD Million)

02-2729-4219

+886-2-2729-4219

License/价格

基于 RNA 的治疗和疫苗市场，按产品类型、应用、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

RNA-based Therapeutics and Vaccines Market, By Product Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

报告要点

基于 RNA 的治疗和疫苗市场細項分析：

基于 RNA 的治疗与疫苗市场-竞争格局：

最近的发展：

目录

第 1 章：基于 RNA 的治疗和疫苗市场概述

第 2 章：执行摘要

第 3 章：基于 RNA 的治疗药物和疫苗主要市场趋势

第 4 章：基于 RNA 的治疗药物和疫苗产业研究

第 5 章：基于 RNA 的治疗和疫苗市场：COVID-19 影响分析

第 6 章：基于 RNA 的治疗与疫苗市场格局

第 7 章：基于 RNA 的治疗和疫苗市场 - 按产品类型

第 8 章：基于 RNA 的治疗和疫苗市场 - 按应用

第 9 章：基于 RNA 的治疗和疫苗市场 - 按最终用户

第 10 章：基于 RNA 的治疗和疫苗市场 - 按地理位置

第 11 章：主要供应商分析 - 基于 RNA 的治疗和疫苗产业

第 12 章：360 度分析师视角

第 13 章：附录

REPORT HIGHLIGHT

RNA-based Therapeutics and Vaccines Market- Segmentation Analysis:

RNA-based Therapeutics and Vaccines Market- Competitive Landscape:

Recent Developments:

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET KEY PLAYERS

GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

GLOBAL RNA-BASED THERAPEUTICS AND VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

Table of Contents

1. RNA-based Therapeutics and Vaccines Market Overview

2. Executive Summary

3. RNA-based Therapeutics and Vaccines Key Market Trends

4. RNA-based Therapeutics and Vaccines Industry Study

5. RNA-based Therapeutics and Vaccines Market: COVID-19 Impact Analysis

6. RNA-based Therapeutics and Vaccines Market Landscape

7. RNA-based Therapeutics and Vaccines Market - By Product Type

8. RNA-based Therapeutics and Vaccines Market - By Application

9. RNA-based Therapeutics and Vaccines Market - By End User

10. RNA-based Therapeutics and Vaccines Market- By Geography

11. Key Vendor Analysis- RNA-based Therapeutics and Vaccines Industry

12. 360 Degree Analyst View

13. Appendix

List of Tables

List of Figures